¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Journal of clinical monitoring and computing."¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
journal
1. ÇмúÁö 2. Àϱâ
area monitoring
±¸¿ª°¨½Ã
air monitoring
´ë±â°¨½Ã
blood glucose monitoring
Ç÷´ç°¨½Ã
central venous pressure monitoring
Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
drug level monitoring
¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
fetal monitoring
žư¨½Ã, žƸð´ÏÅ͸µ
hemodynamic monitoring
Ç÷¿ªÇа¨½Ã, Ç÷¿ªÇиð´ÏÅ͸µ
invasive monitoring
ħ½À°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
intraoperative monitoring
¼ö¼úÁß°¨½Ã
monitoring
°¨½Ã, ¸ð´ÏÅ͸µ
metabolic monitoring
´ë»ç·®Á¶»ç
neuromuscular monitoring
½Å°æ±Ù(À°)°¨½Ã
noninvasive monitoring
ºñħ½À°¨½Ã
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
11
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
diphteria and tetanus toxoids and acellular pert vaccine
°³·®µðÇÇÆ¼
journal
1. ÇмúÁö, 2. Àϱâ
monitoring
°¨½Ã
therapeutic drug monitoring
Ä¡·á¾à¹°³óµµ°¨½Ã
kidney ureter and bladder
ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
clinical
Áø·á-. ÀÓ»ó-
dilatation and curettage
Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
objective structured clinical (OSCE) examination
°´°ü±¸Á¶ÈÁø·á½ÃÇè
clinical manifestation
ÀÓ»óÁõ»ó, ÀÓ»ó¼Ò°ß
clinical trial
ÀÓ»ó½ÃÇè
peritoneal oocyte and sperm transfer
»ý½Ä¼¼Æ÷º¹°³»À̽Ä, »ý½Ä¼¼Æ÷º¹°³»Àü´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
air monitoring
´ë±â°¨½Ã
area monitoring
±¸¿ª°¨½Ã
central venous pressure monitoring
Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
chemotherapeutic drug monitoring
ÈÇпä¹ý¾àÁ¦°¨½Ã
drug level monitoring
¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
fetal monitoring
žư¨½Ã
glucose monitoring
Æ÷µµ´ç°¨½Ã
heparin therapy monitoring
ÇìÆÄ¸°¿ä¹ý°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
intraoperative monitoring
¼ö¼úÁß°¨½Ã
invasive monitoring
ħ½À°¨½Ã
monitoring
°¨½Ã
metabolic monitoring
´ë»ç·®Á¶»ç
neuromuscular monitoring
½Å°æ±ÙÀ°°¨½Ã
noninvasive monitoring
ºñħ½À°¨½Ã
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
hoof and mouth disease =foot and mouth d.
±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
Clinical data
ÀÓ»óÀÚ·á
Clinical skills
ÀÓ»ó¼ú±â
GCP : good clinical practice
ÀÓ»ó½ÃÇè °ü¸®±âÁØ.
Good Clinical Practice(GCP)
ÀǾàǰ ÀÓ»ó½ÃÇè °ü¸®±âÁØ
SCAG, Sandoz Clinical Assessment-Geriatric
»êµµ½º ³ëÀÎÀÓ»óÆò°¡(-ôµµ)
SCAN, Schedule for Clinical Assessment in Neuropsychaitry
½Å°æÁ¤½Å°ú¿¡ ÀÖ¾î ÀÓ»óÆò°¡¸¦ À§ÇÑ ¸ñ·Ï
randomized clinical trial
¹«ÀÛÀ§ÀÓ»ó½ÇÇè
TDM : therapeutic drug monitoring
Ä¡·á¾à¹°³óµµ ¸ð´ÏÅ͸µ.
air monitoring
´ë±â¿À¿°°¨½Ã(ËÀË»ËçËç˧Ëà).
area monitoring
±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
glucose monitoring
Æ÷µµ´ç°¨½Ã
heparin therapy monitoring
ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
personal monitoring
°³ÀÎ (ÇÇÆø)°¨½Ã
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
hoof and mouth disease =foot and mouth d.
±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
papilomatosis of Gougerot and Carteaud => confluent and reticulated pa
air monitoring
´ë±â¿À¿°°¨½Ã(ËÀË»ËçËç˧Ëà).
area monitoring
±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
behavior monitoring program
Çൿ(ÇàÅÂ)°¨½ÃÇÁ·Î±×·¥
chemotherapeutic drug monitoring
ÈÇпä¹ý¾àÁ¦°¨½Ã
drug level monitoring
¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
fetal monitoring
žư¨½Ã.
glucose monitoring
Æ÷µµ´ç°¨½Ã
heparin therapy monitoring
ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
individual monitoring
°³Àθð´ÏÅ͸µ
invasive monitoring
°üÇ÷Àû °¨½Ã.
metabolic monitoring
´ë»ç·®Á¶»ç(¡åÖðàÞÛ).
monitoring
°¨½Ã
neuromuscular monitoring
½Å°æ±Ù°¨½Ã
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½